.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Julphar
Colorcon
Daiichi Sankyo
Citi
Federal Trade Commission
Queensland Health
Harvard Business School
Dow

Generated: September 20, 2017

DrugPatentWatch Database Preview

DIURIL Drug Profile

« Back to Dashboard

Which patents cover Diuril, and when can generic versions of Diuril launch?

Diuril is a drug marketed by Oak Pharms Akorn and Salix Pharms and is included in two NDAs.

The generic ingredient in DIURIL is chlorothiazide. There are forty-one drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the chlorothiazide profile page.

Summary for Tradename: DIURIL

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list3
Bulk Api Vendors: see list52
Patent Applications: see list4,746
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DIURIL at DailyMed

Pharmacology for Tradename: DIURIL

Ingredient-typeThiazides
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms Akorn
DIURIL
chlorothiazide sodium
INJECTABLE;INJECTION011145-005Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Salix Pharms
DIURIL
chlorothiazide
SUSPENSION;ORAL011870-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Oak Pharms Akorn
DIURIL
chlorothiazide
TABLET;ORAL011145-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Oak Pharms Akorn
DIURIL
chlorothiazide
TABLET;ORAL011145-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Cipla
Healthtrust
Queensland Health
Farmers Insurance
Medtronic
Teva
McKinsey
Baxter
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot